Bausch & Lomb is the eye health company dedicated to Perfecting Vision and Enhancing Life®
Bausch & Lomb offers the world’s most comprehensive portfolio of eye health products and
we’re proud that ours is one of the oldest, best known and most respected healthcare brands in
The company began in 1853 in Rochester, New York, as a small optical shop that grew to
become a multi-billion dollar corporation with nearly 14,000 employees worldwide, and with
products available in more than 100 countries.
Bausch & Lomb’s history of innovation continues today as the company invents new materials,
engineers new technologies, and creates pioneering ways to help people see better.
Bausch & Lomb markets five broad categories of products
Bausch & Lomb provides the full spectrum of wearing modalities, including
well-known brand names such as PureVision®
Bausch & Lomb lens care products include the ReNu®
brand of chemical
disinfectants as well as the Sensitive Eyes®
and the Boston®
lines of products for cleaning
The product portfolio treats a wide range of eye conditions including
glaucoma, eye allergies, conjunctivitis and dry eye. We offer proprietary and generic medicines
available by prescription, over-the-counter eye drops and other medications. Our line of
proprietary Rx products includes the steroid eye drops Lotemax®
outside the U.S., the non-selective beta blocker, Carteol®
, preservative-free, single-
dose drops; and Liposic®
ointment for dry eye. Leading OTC products include the Ocuvite®
brands of ocular vitamins and the Advanced Eye Relief
Cataract and vitreoretinal surgery:
Bausch & Lomb’s full suite of products includes intraocular
lenses (IOL) and delivery systems featuring the SofPort®
brands of IOLs, the
™ line of phacoemulsification equipment, and other surgical instruments and devices,
including the Storz®
line of instruments.
The product line for refractive laser surgery includes the Zyoptix®
system for personalised vision correction (customised LASIK) and the Zyoptix® XP
brands of microkeratomes.
Surgical division (outside the US)
Cataract IOL product line
Bausch & Lomb’s IOL portfolio includes the well established, acrylic, hydrophilic Akreos®
of IOLs: the Akreos Adapt
; the Akreos Adapt Advanced Optics (AO)
; and the most recently
available lens, the Akreos
MI-60 lens, specifically designed for implantation through a
The Akreos AO MI-60
is latest addition to the Bausch & Lomb MICS Platform
, a complete
1.8 mm solution for phaco surgery (equipping surgeons with lens and
phaco equipment, as well as the education, techniques and instruments to facilitate the
lens material is biocompatible with a long-term record of safety. Since the first
implantation in July 1998, approximately 1.5 million lenses utilising this material have been
Both the Akreos
Adapt AO and Akreos
MI-60 have an aberration-free, aspheric optic, for
improved quality of vision and preserved depth of field. The 360° posterior ridge and square
edge technology provide an anti-PCO barrier. Bausch & Lomb’s silicone, SofPort
AO lens also
has these design features. The SofPort
AO is available with the EZ-load injector and the Akreos
Further cataract products include Amvisc® Plus
, a moderately cohesive viscoelastic with
dispersive characteristics, the Aqsia™ Balanced Salt Solutions
and the Coatel™ HMPC
Cataract/vitreoretinal equipment product line
The Bausch & Lomb Millennium™ Microsurgical System
delivers on the promise of a platform
with innovative technology for cataract and vitreoretinal surgery. The modular design of the
system allows continuing technology innovations to be integrated into the system.
Specialist vitreoretinal equipment includes the Millennium TSV25™ System
invasive 25 gauge vitreoretinal technology and the Millennium Endolase System
, with an
Microsurgical System also forms an intrinsic part of Bausch & Lomb’s MICS
for 1.8 mm phaco, providing surgeons with:
• MICS Education: Bausch & Lomb University accelerated learning modules including a
specialised education program for MICS and in-theatre training
Instruments: Customised Instruments, including the single use MICS
Platform radically changes 1.8 mm micro-incision surgery by delivering a
complete solution for 1.8 mm phaco techniques that minimises the learning curve and enhances
safety and optimises surgical efficiency.
Software: MICS Platform Millennium Custom Controlled Software (CCS 2006)
optimised power modulations to enhance safety and efficiency during MICS
Two fluidic control options are available with the Millennium
system, either the
Advanced Flow System or Advanced Vacuum System.
Chamber stability is enhanced using the Micro Incision Vacuum Pack (MIVP)
with the Stable
Chamber Tubing System
, which maintains positive intraocular pressure (IOP) during surgery.
Alternatively, the Stable Flow phaco needles
support high vacuum phaco techniques while
providing strong lens fragment holding forces.
Bausch & Lomb offers a range of 19 and 20 gauge irrigating choppers,
knives, and micro capsulorhexis forceps.
The latest anterior technology, the Stellaris
™ Vision Enhancement System (conformity
assessment for CE marking in progress), completes the MICS
Platform for a complete solution
Refractive product line
Bausch & Lomb is proud of the pivotal role its Zyoptix®
platform has played in the development
of today's refractive surgery treatments. Innovations within the Zyoptix®
Platform are enabling
greater predictability and quality, faster diagnostics, improved safety, efficacy and efficiency.
XP Microkeratome with Epi-Separator technology for surface treatments.
The Zyoptix 100 Laser
system provides exceptional clinical results, expanded treatment
algorithms and enhanced safety features. Fast, reliable treatment times are provided by the
100Hz laser. The laser’s enhanced safety features include iris recognition, multi-dimensional
eyetracker and Zy-ID
™ which gives a unique digital map of the iris.
A variety of Zyoptix
treatments provide the best choice for each patient:
The first algorithm to use each patient's unique K-value (corneal curvature) and Q-value (corneal
asphericity) to deliver a true aspheric treatment that significantly reduces surgically – induced
A customised treatment that uses sophisticated wavefront data for optimised outcomes.
Zyoptix Tissue Saving
A treatment designed to minimise tissue removal and maximise treatment efficiency.
Zyoptix Diagnostic Workstation (ZDW):
Integrated diagnostics for customised refractive
treatments. It is a single, modular workstation combining leading technology in corneal
The Orbscan® IIz Corneal Topographer
comprises scanning slit technology with advanced
placido disc system measuring up to 9000 anterior data points in less than 3 seconds. The
system provides a complete analysis and diagnosis of the cornea, full corneal pachymetry,
The Zywave® Wavefront Analyzer
measures and analyses the presence of higher and lower
order aberrations. The ZyID
iris recognition technology provides safe and secure patient
identification throughout the treatment process, as well as compensation for pupil centre shift
and cyclotorsion. The analyser also provides individual 3D aberration maps, dynamic
pupillometry, normal band distribution and refraction data for all pupil diameters.
Zyoptix® Advanced Personalized Technologies (APT)
simplifies the patient workup process
by significantly reducing the complexity and time involved to perform true wavefront-guided
treatments. The NoDiZy feature eliminates the need to pharmaceutically dilate in most Zyoptix
candidates, enabling a faster and easier acquisition. APT also provides swift and
easy storage and transfer of diagnostic data using an enhanced CPU, simplified user interface
and networking capabilities. The Zyoptix Treatment Calculator
software and algorithms
Bausch & Lomb’s Zyoptix TruLink™
proprietary technology allows direct data transfer of
patient treatment files from the Zyoptix Diagnostic Workstation
to the Zyoptix
Zyoptix® XP Microkeratome.
The next-generation microkeratome, the Zyoptix
XP is a
comprehensive microkeratome system that allows surgeons to perform both stromal and
epithelial flaps with consistent and repeatable flap thickness. The precision engineered,
interchangeable components are easy to use and assemble, with built-in safety features and
World-class training and technical support
Bausch & Lomb has an extensive team of Refractive Application Specialists across Europe,
equipped with intensive technical and clinical training and annual certifications to provide
surgeons with excellent technical expertise and support. The Refractive Service Engineers
provide quick and accurate on-site and remote repairs.
The European Centre of Excellence, located at the Bausch & Lomb Global Refractive R&D and
manufacturing facility, based in Munich, Germany, offers customised training programs for
surgeons and staff on all aspects of the company’s refractive technology. The Zyoptix®
Development Program, an e-learning tool, demonstrates Bausch & Lomb’s continuing
commitment to support surgeons and maximise the potential of their refractive clinics.
™/® denotes trademark of Bausch & Lomb Incorporated. Carteol is a trademark of Otsuka Pharmaceutical Co. Ltd.
Majalah Kedokteran FK UKI 2008 Vol XXVI No.1 Januari-Maret Tinjauan Pustaka Infeksi Parasit dan Jamur pada Pasien terinfeksi HIV Agnes Kurniawan,* Retno Wahyuningsih,*,** Lisawati Susanto* *Departemen Parasitologi Fakultas Kedokteran Universitas Indonesia **Bagian Parasitologi Fakultas Kedokteran Universitas Kristen Indonesia Infeksi HIV yang dapat berakhir dengan AIDS merupakan an
ARTÍCULO DE INVESTIGACIÓN ORIGINAL PharmacoEconomics - Spanish Research Articles 6 (2): 33-43, 2009© 2009 Adis Data Information BV. All rights reserved. Análisis del impacto presupuestario de la sustitución de omeprazol i.v. por pantoprazol i.v. en el tratamiento de la úlcera péptica y del reflujo gastroesofágico en España Josep Darbà1 y Gabriela Restovic2 2 BCN Heath Econ